PharmaBoardroom

Interview: Jean-Marc Juteau, Director, Biotech City, Canada

The director of Biotech City in Laval, close to Montreal, discusses the advantages brought on by the cluster effect, and how this has played out at…

Interview: Patrick J. Cashman President & General Manager,…

The head of Lundbeck in Canada talks about the stigma of mental illness that still exists in the country today, and how CNS companies like Lundbeck…

Interview: John Sampalis, CEO, JSS Medical Research, Canada

Industry veteran and CEO of JSS Medical research explains what he thinks is going wrong with clinical research in Canada today, how Canadian CROs are…

Interview: Éric Gervais, Executive Vice President, Médunik…

As the only country in the G8 without an orphan drugs act, the president of Médunik, a company focused on bringing orphan drugs into the country,…

Biotech as business: the Bavarian Nordic story

If there is one thing that successful Danish companies have in common with one another, it is the clear recognition of abundant opportunities outside…

Interview: Calvin Tsai CEO of Orient Pharma & Jack Wu,…

Calvin Tsai and Jack Wu talk about their two-pronged international approach through pharmaceuticals and nutricare. The head of the nutricare business…

Interview: Sybil Dahan, President, Triton Pharma, Canada

An interesting perspective on the Canadian market, and its opportunities and challenges in drug registration on a regional level from the President of…

Interview: Christian Dyvig, CEO, Lundbeck Foundation

The CEO of one of Denmark’s largest foundations talks about the merits of the foundation model, and the current strategies of both Lundbeck and ALK…

Interview: Roberto Bellini, President & CEO, Bellus Health,…

The CEO of Bellus Health outlines his strategy since 2010 to change the focus of the company from Alzheimer’s to a niche disease, AA amyloidosis, as…

Interview: Jon Fairest, President & CEO, Sanofi Canada

The President & CEO of Sanofi Canada talks candidly about the pros and cons of the current administrative setup of the Canadian healthcare…

Interview: Johnsee Lee, Chairman, Development Center for…

A leading figure in the Taiwanese pharmaceutical sector, Lee divulges the practicalities behind ECFA, the free trade agreement that was signed between…

Interview: Raphael Hofstein, President & CEO, MaRS…

The CEO of MaRS Innovation, a commercialization incubator created by 16 of Toronto's best research institutions and supported by the government,…

Tagged with